Applications of Artificial Intelligence in Prostate Cancer Care: A Path to Enhanced Efficiency and Outcomes Targeted therapies have changed the treatment landscape in gynecologic cancer. Studies ...

Allen is a minimally invasive gynecologic surgeon (MIGS), who specializes in non-cancerous gynecological conditions like fibroids and endometriosis. A newer intervention is laparoscopic ...

Trial registration number NCT02026687; Results. regional analgesia gynecological malignancy laparotomy opioid consumption quality improvement This is an open access article distributed in accordance ...

As you age, your nutritional needs change. Before menopause, you should have about 1,000 mg of calcium daily. After menopause, you should have up it to 1,200 mg of calcium per day. Vitamin D is also ...

It's an increase that experts say is dramatic and surprising.Dr. Beman Khulpateea with Mercy Medical Center's Gynecologic Oncology Center said part of the reason behind the increase may be that ...

No gynecological malignancies were seen, while expected incidence was 0.26 or greater for all cancer types. HealthDay News — Short-term testosterone use among transmasculine and gender diverse ...

New research suggests that women with gynecologic conditions may have a higher risk of heart disease and stroke. Endometriosis and polycystic ovary syndrome (PCOS) raised these risks the most ...

Ovarian cancer is the 6th most common cancer in females in the UK, accounting for 4% of all new cancer cases in females (2017-2019). In females and males combined, ovarian cancer is the 16th most ...

“The positive results from this trial add to the growing body of evidence supporting the potential benefit of Keytruda across gynecological cancers, including this difficult-to-treat form of ...

“The positive results from this trial add to the growing body of evidence supporting the potential benefit of [pembrolizumab] across gynecological cancers, including this difficult-to-treat form of ...

Retifanlimab-dlwr (Zynyz) has been granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC), both in combination chemotherapy and ...